A story in the Baltimore Sun concerns a family awarded $21 million over claims that negligent care by Baltimore’s Harbor Hospital caused their child to be born with cerebral palsy.
Jaylan Norfleet, who was 9 years old as of July, has a fully functioning mind but severe disabilities including very limited use of his legs and hands. An attorney representing the family described him as “literally trapped inside his body.”
The family ...
continue reading...
In an analysis piece for Forbes, journalist Ed Silverman writes that the U.S. Food and Drug Administration may have used a flawed statistical model in its evaluation of the bleeding risks for the drug Pradaxa.
Pradaxa is a blood thinner, used to prevent blood clots and strokes in patients with atrial fibrillation. The Institute for Safe Medicine Practices has linked the drug to more than 500 deaths and ...
continue reading...
The U.S. Centers for Disease Control and Prevention is warning health care providers of additional contaminants in drugs made by the New England Compounding Center – a Massachusetts specialty pharmacy blamed for a fungal meningitis outbreak.
The CDC’s alert says bacterial and fungal contaminants were found in cardioplegia, a drug used in heart surgeries, and the steroid medications betamethasone and triamcinolone.
WBIR out of Tennessee reports that all ...
continue reading...
The New York Department of Conservation wants an extension for releasing a new set of rules that would regulate the controversial natural gas extraction method called “hydraulic fracturing” or “fracking.”
The department originally had a Nov. 29 deadline to release the new regulations. But state officials announced their intention to file for a 90-day extension, which the Albany Times Union says could ultimately push back the final release by as ...
continue reading...
A new study finds that the popular heart drug digoxin may cause patients to die sooner, CBS News reports.
The report cites a study recently published online in the European Heart Journal, showing that patients with atrial fibrillation — a condition where the heart’s upper chambers flutter erratically — died in significant numbers while taking digoxin.
Researchers examined data from 4,060 atrial fibrillation patients who took the drug before or during the ...
continue reading...
Many medical professionals are concerned about this week’s decision by the federal appeals court making it legal for pharmaceutical company representatives to market drugs for “off label” uses.
An ABC News report quotes Dr. Richard Deyo, a professor of family medicine at Oregon Health and Science University, as saying: “This risks taking us back to an era when people could promote snake oil without restrictions – a situation I would hate ...
continue reading...
